High Intensity Interval Exercise in Diastolic Heart Failure
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
1 other identifier
interventional
19
1 country
2
Brief Summary
Heart failure is a major health concern and is the leading cause of hospitalization among elderly Americans. Currently 5.7 million Americans are estimated to have heart failure and the estimated direct and indirect costs of treating heart failure are approximately $37.2 billion. Approximately 40% of those diagnosed with heart failure will have heart failure with preserved ejection fraction (HFPEF). These individuals have significant restrictions in their ability to carry out activities of daily living. Exercise training has been established as adjuvant therapy in heart failure. Although exercise training guidelines for treatment of heart failure with reduced ejection fraction (HFREF) are well established, no consensus exercise guidelines exist for management of HFPEF. Aerobic and cardiovascular adaptations are generally greater after high-intensity exercise training; interval-type exercise facilitates this type of training because it allows for rest periods that make it possible for patients with heart failure to perform short (e.g., 1-4 minutes) work periods at intensities that are higher than would be possible during continuous exercise. High-intensity aerobic interval training presents a unique, yet untested, therapeutic modality for the exercise training of patients with heart failure with preserved ejection fraction. Pilot testing is warranted, results of which may have important implications for reducing cardiovascular risk, increasing short- and long-term quality of life and survival, and reducing healthcare costs in this patient population. The investigators primary specific aim is to determine the efficacy of a novel, high-intensity aerobic interval exercise training program for improving VO2peak (peak oxygen uptake), endothelial function, and arterial stiffness in patients with HFPEF. The investigators secondary aim is to determine whether the vascular changes are correlated with the changes in VO2peak.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2010
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 21, 2014
CompletedFirst Posted
Study publicly available on registry
May 28, 2014
CompletedResults Posted
Study results publicly available
April 12, 2019
CompletedApril 12, 2019
January 1, 2019
1.4 years
May 21, 2014
October 5, 2017
April 10, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Left Ventricular Diastolic Dysfunction
Measured using left ventricular echocardiography. Diastolic dysfunction is graded as: normal, grade 1, grade 2, grade 3, grade 4. Increasing grade is indicative of worsening LV dysfunction and worse outcomes. Improvement in LV grade is associated with better long term outcomes.
Before and after the 1 month exercise intervention
Secondary Outcomes (1)
VO2peak
Test carried out before and after the 1 month long exercise intervention.
Other Outcomes (1)
Brachial Artery Flow-mediated Dilation
Before and after 1-month exercise intervention
Study Arms (2)
High intensity interval training
EXPERIMENTALHigh intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
Moderate intensity exercise training
ACTIVE COMPARATOR3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Interventions
3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)
3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)
Eligibility Criteria
You may qualify if:
- HFpEF diagnosis with New York Heart Association heart failure Class II-III symptoms
You may not qualify if:
- Unstable angina
- Myocardial infarction in the past 4 weeks
- Uncompensated heart failure
- New York Heart Association class IV symptoms
- Complex ventricular arrhythmias (at rest or during the maximal exercise test)
- Medical or orthopedic conditions that precluded treadmill walking
- Symptomatic severe aortic stenosis
- Acute pulmonary embolus
- Acute myocarditis
- Medication non-compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arizona State Universitylead
- Mayo Cliniccollaborator
- University of Albertacollaborator
Study Sites (2)
Arizona State University
Phoenix, Arizona, 85004, United States
Mayo Clinic
Scottsdale, Arizona, 85259, United States
Related Publications (1)
Angadi SS, Mookadam F, Lee CD, Tucker WJ, Haykowsky MJ, Gaesser GA. High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study. J Appl Physiol (1985). 2015 Sep 15;119(6):753-8. doi: 10.1152/japplphysiol.00518.2014. Epub 2014 Sep 4.
PMID: 25190739DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Siddhartha S. Angadi, PhD., FACSM
- Organization
- Arizona State University - Downtown Phoenix Campus
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2014
First Posted
May 28, 2014
Study Start
November 1, 2010
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
April 12, 2019
Results First Posted
April 12, 2019
Record last verified: 2019-01